Rallybio Co. (NASDAQ:RLYB) Receives $12.20 Consensus Target Price from Brokerages
Shares of Rallybio Co. (NASDAQ:RLYB – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six analysts that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month target price among […]
More Stories
Syria: WHO Regional Director calls for greater investment in health sector
Failure to invest in the health of the Syrian people will only deepen instability in the war-ravaged country and pose...
Hidden Agendas: How the U.S. Government Masks Inflation and Taxes Citizens to Enrich Leaders
By Stephen Zogopoulos, USNN World News In a stark revelation that shakes the very foundations of American democracy, recent investigations...
Vanguard Personalized Indexing Management LLC Has $1.28 Million Position in Huntington Bancshares Incorporated (NASDAQ:HBAN)
Vanguard Personalized Indexing Management LLC boosted its position in shares of Huntington Bancshares Incorporated (NASDAQ:HBAN – Free Report) by 9.3%...
Janney Capital Management LLC Sells 8,761 Shares of JPMorgan Chase & Co. (NYSE:JPM)
Janney Capital Management LLC decreased its stake in JPMorgan Chase & Co. (NYSE:JPM) by 4.4% during the 4th quarter, according...
JPMorgan Chase & Co. (NYSE:JPM) Shares Sold by Torray Investment Partners LLC
Torray Investment Partners LLC lessened its holdings in JPMorgan Chase & Co. (NYSE:JPM) by 0.3% during the 4th quarter, according...
Foundations Investment Advisors LLC Has $13.98 Million Stock Position in JPMorgan Chase & Co. (NYSE:JPM)
Foundations Investment Advisors LLC grew its holdings in shares of JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 11.1%...